AnHorn Medicines
PrivateLast Round
Series A
Apr 25, 2023
Total Funding Raised
$10M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
AnHorn Medicines is a clinical-stage biotechnology company developing first-in-class and best-in-class drugs for cancers, autoimmune diseases, and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AnHorn Medicines Comparables
Compare AnHorn Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allorion Therapeutics | 83% | |
| Black Diamond Therapeutics | 77% | |
| C4 Therapeutics | 74% | |
AnHorn Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 25, 2023 |
AnHorn Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Chiao Tung University Angel Club | Series A |
| TaiAn Technologies Corp. | Series A |
| Taiwania Capital | Series A |
| Black Marble Capital Management | Series A |
| Industrial Technology Investment Corporation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 17, 2.3x the trailing average.
- Mar 2, 2026
Monthly visitors increased 46% MoM, reaching 1.2K.
AnHorn Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AnHorn Medicines's valuation, stock price, and market status.